arrow
J

Jesús M. Paramio

instituto de investigacion sanitaria hospital 12 de octubre imas12
H指数:47
被引数:6,612

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CABOPRE: Evaluating Perioperative Cabozantinib’s Efficacy and Biomarkers for Cytoreductive Nephrectomy in Advanced Renal Cell Carcinoma

CABOPRE:评估围手术期卡博替尼对晚期肾细胞癌细胞减灭性肾切除术的疗效及生物标志物

Cancers
IF4.4
2026-10-060
OA
UCIPREDICT: LIQUID BIOPSY-BASED PREDICTION OF IMMUNOTHERAPY RESPONSE IN UROTHELIAL CARCINOMA - INTERIM MULTICENTER RESULTS

UCIPREDICT:基于液体活检预测尿路上皮癌免疫治疗反应——中期多中心结果

2026-05-010
PRE
Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models

细胞来源和遗传驱动因素定义了小鼠模型中晚期膀胱癌亚型及潜在的治疗反应

2026-02-230
OAAI
Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer

肿瘤微环境和PD-L1粒度的表征揭示了非浸润性膀胱癌中癌症相关肌成纤维细胞的预后价值

2024-12-190
OAAI
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

靶向组蛋白乙酰化调控膀胱癌肿瘤微环境的研究

2024-01-043
OAAI
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models

CM-272抑制G9a: 使用2D和3D体外模型开发去势抵抗性前列腺癌的新型抗肿瘤策略

2022-06-0112
OAAI
VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma
2020-09-2232
OAAI